Pharmacy

A federal judge has declined to dismiss an antitrust suit against "Pharma Bro" Martin Shkreli and Retrophin, the biotech he founded, according to Bloomberg Law.

Becker's Hospital Review has reported the following five drug or biotech company layoffs in the last two weeks. They are listed below, beginning with the most recent.

Despite pushback from several investors, Bristol-Myers Squibb shareholders voted in favor of its $74 billion acquisition of cancer drugmaker Celgene, according to CNBC.

Find out how your retail pharmacy can leverage its supply chain to match your patients' growing expectations.

Below are more than 100 drug shortages, categorized by 10 therapeutic areas they're commonly used in, according to website Clinical Advisor.

These 10 hospitals and health systems have posted job listings seeking pharmacy leaders in the last week.

Despite pharmaceutical industry pushback, Maryland has approved a first-of-its-kind proposal to create a prescription drug affordability board, according to STAT.

Lawmakers blasted insulin makers and pharmacy benefit managers at the House Energy and Commerce subcommittee hearing on insulin prices April 10, according to STAT.

Now that two of Gilead Science's lucrative, older drugs have lost patent protection, the drugmaker will lay off about 20 percent of its sales team, according to STAT.

Federal prosecutors have charged U.K. drugmaker Indivior with orchestrating a fraud scheme to boost prescriptions of its opioid-addiction treatment Suboxone Film, the U.S. Justice Department announced April 9.